| Cash Flow | 2025-06-27 |
|---|---|
| Stock-based compensation | 97,462 |
| Provision for/(benefit from) credit losses | 2,582 |
| Net income including noncontrolling interest | 206,838 |
| Other non-cash items affecting net income | 17,553 |
| Amortization of operating lease right-of-use assets | 8,193 |
| Prepaid expenses and other assets | -46,972 |
| Other non-current liabilities | -6,063 |
| Operating lease liabilities | -8,237 |
| Inventories | -4,020 |
| Contract liabilities | -1,061 |
| Contract assets, net | 6,902 |
| Income taxes, net | 1,895 |
| Accounts receivable, net | -15,234 |
| Accounts payable and accrued liabilities | -48,979 |
| Depreciation and amortization | 65,829 |
| Deferred income taxes | -9,146 |
| Amortization of premium on investments | 0 |
| Operating lease right-of-use assets | 1,717 |
| Net cash provided by operating activities | 349,367 |
| Proceeds from sale of assets held for sale | 16,881 |
| Proceeds from sales of marketable securities | 15,911 |
| Proceeds from maturities of marketable securities | 0 |
| Purchases of property, plant, and equipment | 20,104 |
| Business combinations, net of cash and restricted cash acquired, and other related payments | 1,362 |
| Purchases of marketable securities | 0 |
| Net cash provided by/(used in) investing activities | 11,326 |
| Proceeds from issuance of common stock | 38,681 |
| Distributions to noncontrolling interest | 1,449 |
| Payment of cash dividend | 95,010 |
| Shares repurchased for tax withholdings on vesting of restricted stock | 35,154 |
| Repurchase of common stock | 89,990 |
| Payment of excise tax on repurchase of common stock | 261 |
| Equity issued in connection with business combination | 0 |
| Net cash used in financing activities | -183,183 |
| Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | 1,302 |
| Net increase/(decrease) in cash, cash equivalents, and restricted cash | 178,812 |
Dolby Laboratories, Inc. (DLB)
Dolby Laboratories, Inc. (DLB)